BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30807778)

  • 1. Inherent biophysical stability of foot-and-mouth disease SAT1, SAT2 and SAT3 viruses.
    Scott KA; Maake L; Botha E; Theron J; Maree FF
    Virus Res; 2019 Apr; 264():45-55. PubMed ID: 30807778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of reverse-transcriptase, real-time PCR assays to distinguish the Southern African Territories (SAT) serotypes 1 and 3 and topotype VII of SAT2 of Foot-and-Mouth Disease Virus.
    Chestley T; Sroga P; Nebroski M; Hole K; Ularamu H; Lung O; Nfon C
    Front Vet Sci; 2022; 9():977761. PubMed ID: 36204292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability.
    Scott KA; Kotecha A; Seago J; Ren J; Fry EE; Stuart DI; Charleston B; Maree FF
    J Virol; 2017 May; 91(10):. PubMed ID: 28298597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
    Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and Molecular Characterization of Foot and Mouth Disease Viruses from Outbreaks in Some States of Northern Nigeria 2013-2015.
    Ehizibolo DO; Haegeman A; De Vleeschauwer AR; Umoh JU; Kazeem HM; Okolocha EC; Van Borm S; De Clercq K
    Transbound Emerg Dis; 2017 Dec; 64(6):1979-1990. PubMed ID: 28097814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis, biophysical stability and phenotypic variance of SAT2 foot-and-mouth disease virus.
    Ramulongo TD; Maree FF; Scott K; Opperman P; Mutowembwa P; Theron J
    Vet Microbiol; 2020 Apr; 243():108614. PubMed ID: 32273026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
    Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J
    J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogeographical and cross-species transmission dynamics of SAT1 and SAT2 foot-and-mouth disease virus in Eastern Africa.
    Omondi G; Alkhamis MA; Obanda V; Gakuya F; Sangula A; Pauszek S; Perez A; Ngulu S; van Aardt R; Arzt J; VanderWaal K
    Mol Ecol; 2019 Jun; 28(11):2903-2916. PubMed ID: 31074125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Epitope Mapping Potential of Single-Chain Antibody Fragments Against Foot-and-Mouth Disease Virus Serotypes A, SAT1, and SAT3.
    Chitray M; Opperman PA; Rotherham L; Fehrsen J; van Wyngaardt W; Frischmuth J; Rieder E; Maree FF
    Front Vet Sci; 2020; 7():475. PubMed ID: 32851044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Population Diversity during Co-Infection of Foot-And-Mouth Disease Virus Serotypes SAT1 and SAT2 in African Buffalo in Kenya.
    Palinski RM; Brito B; Jaya FR; Sangula A; Gakuya F; Bertram MR; Pauszek SJ; Hartwig EJ; Smoliga GR; Obanda V; Omondi GP; VanderWaal K; Arzt J
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.
    Kotecha A; Perez-Martin E; Harvey Y; Zhang F; Ilca SL; Fry EE; Jackson B; Maree F; Scott K; Hecksel CW; Harmsen MM; Mioulet V; Wood B; Juleff N; Stuart DI; Charleston B; Seago J
    Sci Rep; 2018 Sep; 8(1):13654. PubMed ID: 30209254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
    Jackson B; Harvey Y; Perez-Martin E; Wilsden G; Juleff N; Charleston B; Seago J
    Vaccine; 2021 Aug; 39(35):5015-5024. PubMed ID: 34303562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals.
    Chitray M; Grazioli S; Willems T; Tshabalala T; De Vleeschauwer A; Esterhuysen JJ; Brocchi E; De Clercq K; Maree FF
    J Virol Methods; 2018 May; 255():44-51. PubMed ID: 29428400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data.
    Maree FF; Blignaut B; Esterhuysen JJ; de Beer TAP; Theron J; O'Neill HG; Rieder E
    J Gen Virol; 2011 Oct; 92(Pt 10):2297-2309. PubMed ID: 21697350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of transboundary foot-and-mouth disease viruses in Nigeria and Cameroon during 2016.
    Ehizibolo DO; Fish IH; Brito B; Bertram MR; Ardo A; Ularamu HG; Lazarus DD; Wungak YS; Nwosuh CI; Smoliga GR; Hartwig EJ; Pauszek SJ; Dickmu S; Abdoulkadiri S; Arzt J
    Transbound Emerg Dis; 2020 May; 67(3):1257-1270. PubMed ID: 31880066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pH stability of foot-and-mouth disease virus.
    Yuan H; Li P; Ma X; Lu Z; Sun P; Bai X; Zhang J; Bao H; Cao Y; Li D; Fu Y; Chen Y; Bai Q; Zhang J; Liu Z
    Virol J; 2017 Nov; 14(1):233. PubMed ID: 29183342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.